Search

Your search keyword '"Goikolea, J. M."' showing total 97 results
Start Over Author "Goikolea, J. M."
97 results on '"Goikolea, J. M."'

17. Clinical guideline for the treatment of dual pathology in the adult population

Author

San Molina, Luis, Arranz Martí, Belén, Arrojo Romero, Manuel, Becoña Iglesias, Elisardo, Bernardo i Arroyo, Miguel, Caballero Martínez, Luis, Castells Cervelló, Xavier, Cunill, R., Florez, G., Franco Fernández, María Dolores, Garriga, M., Goikolea, J. M., González Pinto Arrillaga, Ana, Landabaso Vázquez, Miguel Ángel, López, A., Martínez Raga, José, Merino, A., Páramo Fernández, Mario, Rubio Valladolid, Gabriel, Safont Lacal, Gemma, Saiz Martínez, Pilar Alejandra, Solà, I., Tirado, J., Torrens Melich, Marta, Zorrilla, I., Grupo de Expertos de la Guía de Práctica Clínica de Patología Dual, Universidade de Santiago de Compostela. Departamento de Psicoloxía Clínica e Psicobioloxía, and Universidade de Santiago de Compostela. Departamento de Psiquiatría, Radioloxía, Saúde Pública, Enfermaría e Medicina

Abstract

SI

Published
2016

18. Guía de práctica clínica para el tratamiento de la patología dual en población adulta

Author

Universidade de Santiago de Compostela. Departamento de Psicoloxía Clínica e Psicobioloxía, Universidade de Santiago de Compostela. Departamento de Psiquiatría, Radioloxía, Saúde Pública, Enfermaría e Medicina, San Molina, Luis, Arranz Martí, Belén, Arrojo Romero, Manuel, Becoña Iglesias, Elisardo, Bernardo i Arroyo, Miguel, Caballero Martínez, Luis, Castells Cervelló, Xavier, Cunill, R., Florez, G., Franco Fernández, María Dolores, Garriga, M., Goikolea, J. M., González Pinto Arrillaga, Ana, Landabaso Vázquez, Miguel Ángel, López, A., Martínez Raga, José, Merino, A., Páramo Fernández, Mario, Rubio Valladolid, Gabriel, Safont Lacal, Gemma, Saiz Martínez, Pilar Alejandra, Solà, I., Tirado, J., Torrens Melich, Marta, Zorrilla, I., Grupo de Expertos de la Guía de Práctica Clínica de Patología Dual, Universidade de Santiago de Compostela. Departamento de Psicoloxía Clínica e Psicobioloxía, Universidade de Santiago de Compostela. Departamento de Psiquiatría, Radioloxía, Saúde Pública, Enfermaría e Medicina, San Molina, Luis, Arranz Martí, Belén, Arrojo Romero, Manuel, Becoña Iglesias, Elisardo, Bernardo i Arroyo, Miguel, Caballero Martínez, Luis, Castells Cervelló, Xavier, Cunill, R., Florez, G., Franco Fernández, María Dolores, Garriga, M., Goikolea, J. M., González Pinto Arrillaga, Ana, Landabaso Vázquez, Miguel Ángel, López, A., Martínez Raga, José, Merino, A., Páramo Fernández, Mario, Rubio Valladolid, Gabriel, Safont Lacal, Gemma, Saiz Martínez, Pilar Alejandra, Solà, I., Tirado, J., Torrens Melich, Marta, Zorrilla, I., and Grupo de Expertos de la Guía de Práctica Clínica de Patología Dual

Published
2016

19. Brain functional changes in first-degree relatives of patients with bipolar disorder: evidence for default mode network dysfunction

Author

Alonso-Lana, S., primary, Valentí, M., additional, Romaguera, A., additional, Sarri, C., additional, Sarró, S., additional, Rodríguez-Martínez, A., additional, Goikolea, J. M., additional, Amann, B. L., additional, Maristany, T., additional, Salvador, R., additional, Vieta, E., additional, McKenna, P. J., additional, and Pomarol-Clotet, E., additional

Published
2016
Full Text
View/download PDF

20. Brain structural changes in schizoaffective disorder compared to schizophrenia and bipolar disorder

Author

Amann, B. L., primary, Canales‐Rodríguez, E. J., additional, Madre, M., additional, Radua, J., additional, Monte, G., additional, Alonso‐Lana, S., additional, Landin‐Romero, R., additional, Moreno‐Alcázar, A., additional, Bonnin, C. M., additional, Sarró, S., additional, Ortiz‐Gil, J., additional, Gomar, J. J., additional, Moro, N., additional, Fernandez‐Corcuera, P., additional, Goikolea, J. M., additional, Blanch, J., additional, Salvador, R., additional, Vieta, E., additional, McKenna, P. J., additional, and Pomarol‐Clotet, E., additional

Published
2015
Full Text
View/download PDF

21. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group

Author

Hibar, D P, Westlye, L T, Doan, N T, Jahanshad, N, Cheung, J W, Ching, C R K, Versace, A, Bilderbeck, A C, Uhlmann, A, Mwangi, B, Krämer, B, Overs, B, Hartberg, C B, Abé, C, Dima, D, Grotegerd, D, Sprooten, E, Bøen, E, Jimenez, E, Howells, F M, Delvecchio, G, Temmingh, H, Starke, J, Almeida, J R C, Goikolea, J M, Houenou, J, Beard, L M, Rauer, L, Abramovic, L, Bonnin, M, Ponteduro, M F, Keil, M, Rive, M M, Yao, N, Yalin, N, Najt, P, Rosa, P G, Redlich, R, Trost, S, Hagenaars, S, Fears, S C, Alonso-Lana, S, van Erp, T G M, Nickson, T, Chaim-Avancini, T M, Meier, T B, Elvsåshagen, T, Haukvik, U K, Lee, W H, Schene, A H, Lloyd, A J, Young, A H, Nugent, A, Dale, A M, Pfennig, A, McIntosh, A M, Lafer, B, Baune, B T, Ekman, C J, Zarate, C A, Bearden, C E, Henry, C, Simhandl, C, McDonald, C, Bourne, C, Stein, D J, Wolf, D H, Cannon, D M, Glahn, D C, Veltman, D J, Pomarol-Clotet, E, Vieta, E, Canales-Rodriguez, E J, Nery, F G, Duran, F L S, Busatto, G F, Roberts, G, Pearlson, G D, Goodwin, G M, Kugel, H, Whalley, H C, Ruhe, H G, Soares, J C, Fullerton, J M, Rybakowski, J K, Savitz, J, Chaim, K T, Fatjó-Vilas, M, Soeiro-de-Souza, M G, Boks, M P, Zanetti, M V, Otaduy, M C G, Schaufelberger, M S, Alda, M, Ingvar, M, Phillips, M L, Kempton, M J, Bauer, M, Landén, M, Lawrence, N S, van Haren, N E M, Horn, N R, Freimer, N B, Gruber, O, Schofield, P R, Mitchell, P B, Kahn, R S, Lenroot, R, Machado-Vieira, R, Ophoff, R A, Sarró, S, Frangou, S, Satterthwaite, T D, Hajek, T, Dannlowski, U, Malt, U F, Arolt, V, Gattaz, W F, Drevets, W C, Caseras, X, Agartz, I, Thompson, P M, and Andreassen, O A

Abstract

Despite decades of research, the pathophysiology of bipolar disorder (BD) is still not well understood. Structural brain differences have been associated with BD, but results from neuroimaging studies have been inconsistent. To address this, we performed the largest study to date of cortical gray matter thickness and surface area measures from brain magnetic resonance imaging scans of 6503 individuals including 1837 unrelated adults with BD and 2582 unrelated healthy controls for group differences while also examining the effects of commonly prescribed medications, age of illness onset, history of psychosis, mood state, age and sex differences on cortical regions. In BD, cortical gray matter was thinner in frontal, temporal and parietal regions of both brain hemispheres. BD had the strongest effects on left pars opercularis (Cohen’s d=-0.293; P=1.71 × 10-21), left fusiform gyrus (d=-0.288; P=8.25 × 10-21) and left rostral middle frontal cortex (d=-0.276; P=2.99 × 10-19). Longer duration of illness (after accounting for age at the time of scanning) was associated with reduced cortical thickness in frontal, medial parietal and occipital regions. We found that several commonly prescribed medications, including lithium, antiepileptic and antipsychotic treatment showed significant associations with cortical thickness and surface area, even after accounting for patients who received multiple medications. We found evidence of reduced cortical surface area associated with a history of psychosis but no associations with mood state at the time of scanning. Our analysis revealed previously undetected associations and provides an extensive analysis of potential confounding variables in neuroimaging studies of BD.

Published
2018
Full Text
View/download PDF

33. Trastorno bipolar asociado al uso de sustancias adictivas (patología dual). Revisión sistemática de la evidencia científica y consenso entre profesionales expertos.

Author

Casas, M., Franco, M. D., Goikolea, J. M., Jiménez-Arriero, M. Á., Martínez-Raga, J., Roncero, C., and Szerman, N.

Subjects
*DUAL diagnosis patients, *MENTAL illness treatment, *DIAGNOSIS of bipolar disorder, *SUBSTANCE abuse diagnosis, *MEDLINE
Abstract

The present work focuses on the so-called dual diagnosis (DD): bipolar disorder (BD) associated with substance use disorders (SUD). Although the psychiatrists who treat patients with BD and physicians in charge of patients with SUD frequently find this association with DD, unfortunately there are few scientific works that have studied this association. The Spanish Working Group on Bipolar Disorders in Dual Diagnosis reviewed the published material using a Medline search and selected the most relevant articles. Following this, the Work Group developed an expert consensus in DD and finally, a survey was performed among a group of experts in this disorder to cover the areas that were not fully addressed by the scientific evidence or in those areas in which the Work Group was unable to reach a consensus. We conclude that, in view of the above, establishment of a consensus is a valid tool to complement the current scientific evidence. [ABSTRACT FROM AUTHOR]

Published
2008

34. What we learn about bipolar disorder from large-scale neuroimaging

Author

Christian K. Tamnes, Bartholomeus C M Haarman, Jair C. Soares, Ole A. Andreassen, Viola Oertel, Theodore D. Satterthwaite, G. Tronchin, Michael Stäblein, Bradley J. MacIntosh, Melissa Pauling, Christopher R.K. Ching, Daniel H. Wolf, Dick J. Veltman, Ingrid Agartz, Bernhard T. Baune, Salvador Sarró, Mon-Ju Wu, Scott C Fears, Eduard Vieta, Melissa J. Green, Neeltje E.M. van Haren, Yann Quidé, Erlend Bøen, Yash Patel, Igor Nenadic, Martin Alda, Lisa T. Eyler, Arnaud Pouchon, Danai Dima, Tomáš Paus, Irene Bollettini, Torbjørn Elvsåshagen, Rachel M. Brouwer, Lakshmi N. Yatham, Michael Bauer, Caterina del Mar Bonnín, C. McDonald, Udo Dannlowski, Bronwyn Overs, Edith Pomarol-Clotet, Cristian Vargas Upegui, Oliver Gruber, Henricus G. Ruhé, Márcio Gerhardt Soeiro-de-Souza, Edouard Duchesnay, Hilary P. Blumberg, Tilo Kircher, Miho Ota, Michael Berk, Christoph Abé, Andreas Jansen, Kang Sim, Heather C. Whalley, Derrek P. Hibar, Roel A. Ophoff, Georgios V Thomaidis, Henrik Walter, Sophia Frangou, Michèle Wessa, Dara M. Cannon, Cara M. Altimus, Allison C. Nugent, Rodrigo Machado-Vieira, Orwa Dandash, Marcella Bellani, Unn K. Haukvik, Philip B. Mitchell, Ling-Li Zeng, Christian Knöchel, Jose Manuel Goikolea, Sonja M C de Zwarte, Francesco Benedetti, Sara Poletti, Janice M. Fullerton, Carlos A. Zarate, Aart H. Schene, Dan J. Stein, Chantal Henry, Tristram A. Lett, Mikael Landén, Daniel L Pham, Paolo Brambilla, Silvia Alonso-Lana, Sophia I. Thomopoulos, Carlos López-Jaramillo, Tomas Hajek, Bernd Kramer, G. Delvecchio, Maria M. Rive, Lars T. Westlye, Erick J. Canales-Rodríguez, Victoria L. Ives-Deliperi, Dominik Grotegerd, Beny Lafer, Abraham Nunes, Carrie E. Bearden, Raymond Salvador, Joaquim Radua, Amy C Bilderbeck, Xavier Caseras, Paul M. Thompson, Jorge R. C. Almeida, Pauline Favre, Gloria Roberts, David C. Glahn, Dag Alnæs, Julian A Pineda-Zapata, Tiril P. Gurholt, Mircea Polosan, Josselin Houenou, Fabiano G. Nery, Leila Nabulsi, Mary L. Phillips, Fleur M. Howells, Ana M. Díaz-Zuluaga, Elisa M T Melloni, Ching, C. R. K., Hibar, D. P., Gurholt, T. P., Nunes, A., Thomopoulos, S. I., Abe, C., Agartz, I., Brouwer, R. M., Cannon, D. M., de Zwarte, S. M. C., Eyler, L. T., Favre, P., Hajek, T., Haukvik, U. K., Houenou, J., Landen, M., Lett, T. A., Mcdonald, C., Nabulsi, L., Patel, Y., Pauling, M. E., Paus, T., Radua, J., Soeiro-de-Souza, M. G., Tronchin, G., van Haren, N. E. M., Vieta, E., Walter, H., Zeng, L. -L., Alda, M., Almeida, J., Alnaes, D., Alonso-Lana, S., Altimus, C., Bauer, M., Baune, B. T., Bearden, C. E., Bellani, M., Benedetti, F., Berk, M., Bilderbeck, A. C., Blumberg, H. P., Boen, E., Bollettini, I., del Mar Bonnin, C., Brambilla, P., Canales-Rodriguez, E. J., Caseras, X., Dandash, O., Dannlowski, U., Delvecchio, G., Diaz-Zuluaga, A. M., Dima, D., Duchesnay, E., Elvsashagen, T., Fears, S. C., Frangou, S., Fullerton, J. M., Glahn, D. C., Goikolea, J. M., Green, M. J., Grotegerd, D., Gruber, O., Haarman, B. C. M., Henry, C., Howells, F. M., Ives-Deliperi, V., Jansen, A., Kircher, T. T. J., Knochel, C., Kramer, B., Lafer, B., Lopez-Jaramillo, C., Machado-Vieira, R., Macintosh, B. J., Melloni, E. M. T., Mitchell, P. B., Nenadic, I., Nery, F., Nugent, A. C., Oertel, V., Ophoff, R. A., Ota, M., Overs, B. J., Pham, D. L., Phillips, M. L., Pineda-Zapata, J. A., Poletti, S., Polosan, M., Pomarol-Clotet, E., Pouchon, A., Quide, Y., Rive, M. M., Roberts, G., Ruhe, H. G., Salvador, R., Sarro, S., Satterthwaite, T. D., Schene, A. H., Sim, K., Soares, J. C., Stablein, M., Stein, D. J., Tamnes, C. K., Thomaidis, G. V., Upegui, C. V., Veltman, D. J., Wessa, M., Westlye, L. T., Whalley, H. C., Wolf, D. H., Wu, M. -J., Yatham, L. N., Zarate, C. A., Thompson, P. M., and Andreassen, O. A.

Subjects
mega-analysis, Stress-related disorders Donders Center for Medical Neuroscience [Radboudumc 13], cortical surface area, Review Article, 0302 clinical medicine, Manic-depressive illness, Multicenter Studies as Topic, Spectrum disorder, Review Articles, bipolar disorder, Cerebral Cortex, Trastorn bipolar, neuroimaging, Radiological and Ultrasound Technology, 05 social sciences, ENIGMA, HUMAN BRAIN, Magnetic Resonance Imaging, psychiatry, 3. Good health, Neurology, Meta-analysis, Scale (social sciences), Anatomy, Psychology, Clinical risk factor, Clinical psychology, MRI, MAJOR PSYCHIATRIC-DISORDERS, Schizoaffective disorder, 050105 experimental psychology, 03 medical and health sciences, Magnetic resonance imaging, Neuroimaging, Meta-Analysis as Topic, SDG 3 - Good Health and Well-being, Imatges per ressonància magnètica, medicine, Humans, 0501 psychology and cognitive sciences, Radiology, Nuclear Medicine and imaging, Bipolar disorder, HIPPOCAMPAL VOLUMES, mega‐analysis, GRAY-MATTER VOLUME, SPECTRUM DISORDER, volume, DIABETES-MELLITUS, cortical thickness, COGNITIVE IMPAIRMENT, medicine.disease, Mental illness, meta-analysis, meta‐analysis, RC0321, Neurology (clinical), SCHIZOAFFECTIVE DISORDER, PSYCHOTIC FEATURES, 030217 neurology & neurosurgery
Abstract

MRI‐derived brain measures offer a link between genes, the environment and behavior and have been widely studied in bipolar disorder (BD). However, many neuroimaging studies of BD have been underpowered, leading to varied results and uncertainty regarding effects. The Enhancing Neuro Imaging Genetics through Meta‐Analysis (ENIGMA) Bipolar Disorder Working Group was formed in 2012 to empower discoveries, generate consensus findings and inform future hypothesis‐driven studies of BD. Through this effort, over 150 researchers from 20 countries and 55 institutions pool data and resources to produce the largest neuroimaging studies of BD ever conducted. The ENIGMA Bipolar Disorder Working Group applies standardized processing and analysis techniques to empower large‐scale meta‐ and mega‐analyses of multimodal brain MRI and improve the replicability of studies relating brain variation to clinical and genetic data. Initial BD Working Group studies reveal widespread patterns of lower cortical thickness, subcortical volume and disrupted white matter integrity associated with BD. Findings also include mapping brain alterations of common medications like lithium, symptom patterns and clinical risk profiles and have provided further insights into the pathophysiological mechanisms of BD. Here we discuss key findings from the BD working group, its ongoing projects and future directions for large‐scale, collaborative studies of mental illness., This review discusses the major challenges facing neuroimaging research of bipolar disorder and highlights the major accomplishments, ongoing challenges and future goals of the ENIGMA Bipolar Disorder Working Group.

Published
2022
Full Text
View/download PDF

35. Association between body mass index and subcortical brain volumes in bipolar disorders–ENIGMA study in 2735 individuals

Author

Eduard Vieta, Jose Manuel Goikolea, Joaquim Raduà, Janice M. Fullerton, Lakshmi N. Yatham, Peter R. Schofield, Carlos López-Jaramillo, Tomas Hajek, Edith Pomarol-Clotet, Henk Temmingh, Francesco Benedetti, Ulrik Fredrik Malt, Erlend Bøen, Roel A. Ophoff, Bartholomeus C M Haarman, Cristian Vargas, Kang Sim, Katharina Thiel, Ole A. Andreassen, Tim Hahn, Lisa T. Eyler, Philip B. Mitchell, Christopher R.K. Ching, Axel Krug, Jonathan Repple, Annabel Vreeker, Dara M. Cannon, Sandra Meier, Colm McDonald, Holly Van Gestel, Hannah Lemke, Maike Richter, Caterina del Mar Bonnín, Udo Dannlowski, Tilo Kircher, Martin Alda, Mikael Landén, Janik Goltermann, Torbjørn Elvsåshagen, Genevieve McPhilemy, Jonathan Savitz, Susanne Meinert, Igor Nenadic, Simon Schmitt, Bronwyn Overs, Katharina Brosch, Dan J. Stein, Raymond Salvador, Dominik Grotegerd, Nils Opel, Martin Ingvar, Sean R. McWhinney, Erick J. Canales-Rodríguez, Elena Mazza, Gloria Roberts, Paul M. Thompson, Neeltje E.M. van Haren, Tiana Borgers, Fiona M. Martyn, Frederike Stein, Julia-Katharina Pfarr, Benny Liberg, Julian A Pineda-Zapata, Christoph Abé, Lena Waltemate, Tina Meller, Kai Ringwald, Ana M. Díaz-Zuluaga, Elisa M T Melloni, Rayus Kuplicki, Leila Nabulsi, Fleur M. Howells, Psychiatry, Child and Adolescent Psychiatry / Psychology, Mcwhinney, S. R., Abe, C., Alda, M., Benedetti, F., Boen, E., del Mar Bonnin, C., Borgers, T., Brosch, K., Canales-Rodriguez, E. J., Cannon, D. M., Dannlowski, U., Diaz-Zuluaga, A. M., Elvsashagen, T., Eyler, L. T., Fullerton, J. M., Goikolea, J. M., Goltermann, J., Grotegerd, D., Haarman, B. C. M., Hahn, T., Howells, F. M., Ingvar, M., Kircher, T. T. J., Krug, A., Kuplicki, R. T., Landen, M., Lemke, H., Liberg, B., Lopez-Jaramillo, C., Malt, U. F., Martyn, F. M., Mazza, E., Mcdonald, C., Mcphilemy, G., Meier, S., Meinert, S., Meller, T., Melloni, E. M. T., Mitchell, P. B., Nabulsi, L., Nenadic, I., Opel, N., Ophoff, R. A., Overs, B. J., Pfarr, J. -K., Pineda-Zapata, J. A., Pomarol-Clotet, E., Radua, J., Repple, J., Richter, M., Ringwald, K. G., Roberts, G., Salvador, R., Savitz, J., Schmitt, S., Schofield, P. R., Sim, K., Stein, D. J., Stein, F., Temmingh, H. S., Thiel, K., van Haren, N. E. M., Gestel, H. V., Vargas, C., Vieta, E., Vreeker, A., Waltemate, L., Yatham, L. N., Ching, C. R. K., Andreassen, O., Thompson, P. M., Hajek, T., and Clinical Cognitive Neuropsychiatry Research Program (CCNP)

Subjects
medicine.medical_specialty, Bipolar Disorder, Hippocampus, Amygdala, Article, Body Mass Index, Cellular and Molecular Neuroscience, Lateral ventricles, SDG 3 - Good Health and Well-being, Neuroimaging, Internal medicine, medicine, Humans, Risk factor, Molecular Biology, business.industry, Brain, medicine.disease, Magnetic Resonance Imaging, Obesity, Comorbidity, Psychiatry and Mental health, medicine.anatomical_structure, Cardiology, business, Body mass index, Neuroscience
Abstract

Individuals with bipolar disorders (BD) frequently suffer from obesity, which is often associated with neurostructural alterations. Yet, the effects of obesity on brain structure in BD are under-researched. We obtained MRI-derived brain subcortical volumes and body mass index (BMI) from 1134 BD and 1601 control individuals from 17 independent research sites within the ENIGMA-BD Working Group. We jointly modeled the effects of BD and BMI on subcortical volumes using mixed-effects modeling and tested for mediation of group differences by obesity using nonparametric bootstrapping. All models controlled for age, sex, hemisphere, total intracranial volume, and data collection site. Relative to controls, individuals with BD had significantly higher BMI, larger lateral ventricular volume, and smaller volumes of amygdala, hippocampus, pallidum, caudate, and thalamus. BMI was positively associated with ventricular and amygdala and negatively with pallidal volumes. When analyzed jointly, both BD and BMI remained associated with volumes of lateral ventricles and amygdala. Adjusting for BMI decreased the BD vs control differences in ventricular volume. Specifically, 18.41% of the association between BD and ventricular volume was mediated by BMI (Z = 2.73, p = 0.006). BMI was associated with similar regional brain volumes as BD, including lateral ventricles, amygdala, and pallidum. Higher BMI may in part account for larger ventricles, one of the most replicated findings in BD. Comorbidity with obesity could explain why neurostructural alterations are more pronounced in some individuals with BD. Future prospective brain imaging studies should investigate whether obesity could be a modifiable risk factor for neuroprogression.

Published
2021
Full Text
View/download PDF

36. Longitudinal structural brain changes in bipolar disorder: A multicenter neuroimaging study of 1232 individuals by the ENIGMA Bipolar Disorder Working Group

Author

Theophilus N. Akudjedu, Frederike Stein, Edith Pomarol-Clotet, Lars T. Westlye, Ulrik Fredrik Malt, Erlend Bøen, Fabian Breuer, Chao Suo, Tina Meller, Tim Hahn, Francesco Benedetti, Jose Manuel Goikolea, Silvia Alonso-Lana, Adam George White, Dag Alnæs, Julia-Katharina Pfarr, Beathe Haatveit, Sara Poletti, Kai Ringwald, Nathalia Zak, Benny Liberg, Kelvin Sarink, Giulia Tronchin, Yann Chye, Janice M. Fullerton, Orwa Dandash, Igor Nenadic, Caterina del Mar Bonnín, Elisa M T Melloni, Udo Dannlowski, Michael Berk, Dominik Grotegerd, Christopher R.K. Ching, Lukas Fisch, Torbjørn Elvsåshagen, Andreas Dahl, Martin Alda, Francesco Panicalli, Ingrid Agartz, Martin Ingvar, Bronwyn Overs, Joaquim Radua, Katharina Brosch, Alexander V. Lebedev, Kang Sim, Tilo Kircher, Leila Nabulsi, Dara M. Cannon, Erick J. Canales-Rodríguez, Paul M. Thompson, Nils Opel, Jonathan Repple, R. Salvador, Katharina Dohm, Philip B. Mitchell, Colm McDonald, Salvador Sarró, Rachel M. Brouwer, Ole A. Andreassen, Tomas Hajek, Mikael Landén, Simon Schmitt, Sophia I. Thomopoulos, Elena Rodriguez-Cano, Eduard Vieta, Ingrid Melle, Rhoshel K. Lenroot, Lakshmi N. Yatham, Sean R. McWhinney, Gloria Roberts, Christoph Abé, Walter Heindel, Abe, C., Ching, C. R. K., Liberg, B., Lebedev, A. V., Agartz, I., Akudjedu, T. N., Alda, M., Alnaes, D., Alonso-Lana, S., Benedetti, F., Berk, M., Boen, E., Bonnin, C. D. M., Breuer, F., Brosch, K., Brouwer, R. M., Canales-Rodriguez, E. J., Cannon, D. M., Chye, Y., Dahl, A., Dandash, O., Dannlowski, U., Dohm, K., Elvsashagen, T., Fisch, L., Fullerton, J. M., Goikolea, J. M., Grotegerd, D., Haatveit, B., Hahn, T., Hajek, T., Heindel, W., Ingvar, M., Sim, K., Kircher, T. T. J., Lenroot, R. K., Malt, U. F., Mcdonald, C., Mcwhinney, S. R., Melle, I., Meller, T., Melloni, E. M. T., Mitchell, P. B., Nabulsi, L., Nenadic, I., Opel, N., Overs, B. J., Panicalli, F., Pfarr, J. -K., Poletti, S., Pomarol-Clotet, E., Radua, J., Repple, J., Ringwald, K. G., Roberts, G., Rodriguez-Cano, E., Salvador, R., Sarink, K., Sarro, S., Schmitt, S., Stein, F., Suo, C., Thomopoulos, S. I., Tronchin, G., Vieta, E., Westlye, L. T., White, A. G., Yatham, L. N., Zak, N., Thompson, P. M., Andreassen, O. A., Landen, M., Complex Trait Genetics, and Amsterdam Neuroscience - Complex Trait Genetics

Subjects
Adult, Male, Longitudinal study, medicine.medical_specialty, Bipolar disorder, Neuroimaging, volume changes, surface-based analysis, Young Adult, gray-matter, Cortex (anatomy), Internal medicine, medicine, Humans, Multicenter Studies as Topic, Biological Psychiatry, mri, human cerebral-cortex, Psychiatry, medicine.diagnostic_test, business.industry, ENIGMA, Brain, Magnetic resonance imaging, Cerebral Cortical Thinning, Middle Aged, cortical thickness, medicine.disease, Magnetic Resonance Imaging, Neuroprogression, Mania, genetic influences, medicine.anatomical_structure, Mood, Meta-analysis, Cardiology, lithium treatment, Female, medicine.symptom, i disorder, business, metaanalysis
Abstract

Background: Bipolar disorder (BD) is associated with cortical and subcortical structural brain abnormalities. It is unclear whether such alterations progressively change over time, and how this is related to the number of mood episodes. To address this question, we analyzed a large and diverse international sample with longitudinal magnetic resonance imaging (MRI) and clinical data to examine structural brain changes over time in BD. Methods: Longitudinal structural MRI and clinical data from the ENIGMA (Enhancing Neuro Imaging Genetics through Meta Analysis) BD Working Group, including 307 patients with BD and 925 healthy control subjects, were collected from 14 sites worldwide. Male and female participants, aged 40 ± 17 years, underwent MRI at 2 time points. Cortical thickness, surface area, and subcortical volumes were estimated using FreeSurfer. Annualized change rates for each imaging phenotype were compared between patients with BD and healthy control subjects. Within patients, we related brain change rates to the number of mood episodes between time points and tested for effects of demographic and clinical variables. Results: Compared with healthy control subjects, patients with BD showed faster enlargement of ventricular volumes and slower thinning of the fusiform and parahippocampal cortex (0.18 < d < 0.22). More (hypo)manic episodes were associated with faster cortical thinning, primarily in the prefrontal cortex. Conclusions: In the hitherto largest longitudinal MRI study on BD, we did not detect accelerated cortical thinning but noted faster ventricular enlargements in BD. However, abnormal frontocortical thinning was observed in association with frequent manic episodes. Our study yields insights into disease progression in BD and highlights the importance of mania prevention in BD treatment.

Published
2022
Full Text
View/download PDF

37. In vivo hippocampal subfield volumes in bipolar disorder-A mega-analysis from The Enhancing Neuro Imaging Genetics throughMeta-AnalysisBipolar Disorder Working Group

Author

Sophia I. Thomopoulos, Julian A Pineda-Zapata, Ronny Redlich, Bartholomeus C M Haarman, Mathew A. Harris, Orwa Dandash, Ulrik Fredrik Malt, Lauren E. Salminen, Michael Stäblein, Theo G.M. van Erp, Gloria Roberts, Michael Berk, Jochen Bauer, Edith Pomarol-Clotet, Carlos López-Jaramillo, Dominik Grotegerd, Tomas Hajek, Paul M. Thompson, Philipp G. Sämann, Francesco Benedetti, Tilo Kircher, Brian Hallahan, Jonathan Repple, Lena Waltemate, Maria M. Rive, Heather C. Whalley, Caterina del Mar Bonnín, Oliver Gruber, Igor Nenadic, Udo Dannlowski, Henricus G. Ruhé, Raymond Salvador, Bronwyn Overs, Torbjørn Elvsåshagen, Márcio Gerhardt Soeiro-de-Souza, Ana M. Díaz-Zuluaga, Katharina Förster, Jose Manuel Goikolea, Emma L. Hawkins, Vera Lonning, Silvia Alonso-Lana, Dan J. Stein, Theophilus N. Akudjedu, Elisa M T Melloni, Dag Alnæs, Nils Opel, Martin Alda, Rayus Kuplicki, Erlend Bøen, Salvador Sarró, Unn K. Haukvik, Philip B. Mitchell, Kang Sim, Lisa Rauer, Ole A. Andreassen, Colm McDonald, Eduard Vieta, Erick J. Canales-Rodríguez, Axel Krug, Viola Oertel, Frederike Stein, Xavier Caseras, Christopher R.K. Ching, Lucio Oldani, Dara M. Cannon, Andrew M. McIntosh, Kjetil Nordbø Jørgensen, Ingrid Melle, Rhoshel K. Lenroot, Lars T. Westlye, Giuseppe Delvecchio, Dick J. Veltman, Mar Fatjó-Vilas, Trine Vik Lagerberg, Leila Nabulsi, Henk Temmingh, Carina Hülsmann, Francesco Bettella, Paolo Brambilla, Dennis van der Meer, Sonya Foley, Tiril P. Gurholt, Fleur M. Howells, Joaquim Radua, Thomas M. Lancaster, Christian K. Tamnes, Maria Cg Otaduy, Jonathan Savitz, Stener Nerland, Genevieve McPhilemy, Janice M. Fullerton, Aart H. Schene, Neda Jahanshad, Ingrid Agartz, Bernhard T. Baune, Beathe Haatveit, Bernd Krämer, Psychiatrie & Neuropsychologie, RS: MHeNs - R2 - Mental Health, Haukvik, U. K., Gurholt, T. P., Nerland, S., Elvsashagen, T., Akudjedu, T. N., Alda, M., Alnaes, D., Alonso-Lana, S., Bauer, J., Baune, B. T., Benedetti, F., Berk, M., Bettella, F., Boen, E., Bonnin, C. M., Brambilla, P., Canales-Rodriguez, E. J., Cannon, D. M., Caseras, X., Dandash, O., Dannlowski, U., Delvecchio, G., Diaz-Zuluaga, A. M., van Erp, T. G. M., Fatjo-Vilas, M., Foley, S. F., Forster, K., Fullerton, J. M., Goikolea, J. M., Grotegerd, D., Gruber, O., Haarman, B. C. M., Haatveit, B., Hajek, T., Hallahan, B., Harris, M., Hawkins, E. L., Howells, F. M., Hulsmann, C., Jahanshad, N., Jorgensen, K. N., Kircher, T., Kramer, B., Krug, A., Kuplicki, R., Lagerberg, T. V., Lancaster, T. M., Lenroot, R. K., Lonning, V., Lopez-Jaramillo, C., Malt, U. F., Mcdonald, C., Mcintosh, A. M., Mcphilemy, G., van der Meer, D., Melle, I., Melloni, E. M. T., Mitchell, P. B., Nabulsi, L., Nenadic, I., Oertel, V., Oldani, L., Opel, N., Otaduy, M. C. G., Overs, B. J., Pineda-Zapata, J. A., Pomarol-Clotet, E., Radua, J., Rauer, L., Redlich, R., Repple, J., Rive, M. M., Roberts, G., Ruhe, H. G., Salminen, L. E., Salvador, R., Sarro, S., Savitz, J., Schene, A. H., Sim, K., Soeiro-de-Souza, M. G., Stablein, M., Stein, D. J., Stein, F., Tamnes, C. K., Temmingh, H. S., Thomopoulos, S. I., Veltman, D. J., Vieta, E., Waltemate, L., Westlye, L. T., Whalley, H. C., Samann, P. G., Thompson, P. M., Ching, C. R. K., Andreassen, O. A., Agartz, I., Clinical Cognitive Neuropsychiatry Research Program (CCNP), Psychiatry, Anatomy and neurosciences, Amsterdam Neuroscience - Brain Imaging, Amsterdam Neuroscience - Compulsivity, Impulsivity & Attention, Amsterdam Neuroscience - Mood, Anxiety, Psychosis, Stress & Sleep, and Adult Psychiatry

Subjects
structural brain MRI, Bipolar Disorder, HALOPERIDOL, hippocampus, Stress-related disorders Donders Center for Medical Neuroscience [Radboudumc 13], SEGMENTATION, Hippocampus, Hippocampal formation, 0302 clinical medicine, SCHIZOPHRENIA, Manic-depressive illness, psychosis, BRAIN, Research Articles, Trastorn bipolar, Radiological and Ultrasound Technology, 05 social sciences, Subiculum, ATLAS, Magnetic Resonance Imaging, Liti, 3. Good health, medicine.anatomical_structure, Neurology, Schizophrenia, lithium, Anatomy, Hippocampus (Brain), Research Article, MRI, INTERNEURONS, Psychosis, Hipocamp (Cervell), Neuroimaging, Amygdala, 050105 experimental psychology, CELL-PROLIFERATION, 03 medical and health sciences, Genetics, medicine, Humans, 0501 psychology and cognitive sciences, Radiology, Nuclear Medicine and imaging, Bipolar disorder, large‐scale, LITHIUM-TREATED PATIENTS, business.industry, Dentate gyrus, medicine.disease, nervous system, DENTATE GYRUS, large-scale, bipolar disorder subtype, Neurology (clinical), business, Neuroscience, 030217 neurology & neurosurgery
Abstract

The hippocampus consists of anatomically and functionally distinct subfields that may be differentially involved in the pathophysiology of bipolar disorder (BD). Here we, the Enhancing NeuroImaging Genetics through Meta‐Analysis Bipolar Disorder workinggroup, study hippocampal subfield volumetry in BD. T1‐weighted magnetic resonance imaging scans from 4,698 individuals (BD = 1,472, healthy controls [HC] = 3,226) from 23 sites worldwide were processed with FreeSurfer. We used linear mixed‐effects models and mega‐analysis to investigate differences in hippocampal subfield volumes between BD and HC, followed by analyses of clinical characteristics and medication use. BD showed significantly smaller volumes of the whole hippocampus (Cohen's d = −0.20), cornu ammonis (CA)1 (d = −0.18), CA2/3 (d = −0.11), CA4 (d = −0.19), molecular layer (d = −0.21), granule cell layer of dentate gyrus (d = −0.21), hippocampal tail (d = −0.10), subiculum (d = −0.15), presubiculum (d = −0.18), and hippocampal amygdala transition area (d = −0.17) compared to HC. Lithium users did not show volume differences compared to HC, while non‐users did. Antipsychotics or antiepileptic use was associated with smaller volumes. In this largest study of hippocampal subfields in BD to date, we show widespread reductions in nine of 12 subfields studied. The associations were modulated by medication use and specifically the lack of differences between lithium users and HC supports a possible protective role of lithium in BD., The hippocampus consists of anatomically and functionally distinct subfields that may be differentially involved in the pathophysiology of bipolar disorder.In the largest study of hippocampal subfields in bipolar disorder to date, from 23 sites worldwide, we report widespread reductions in nine of 12 subfields.The lack of differences between lithium users and healthy controls supports a possible protective role of lithium in bipolar disorder.

Published
2022
Full Text
View/download PDF

38. Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders

Author

Committee, Writing, Disorder, Autism Spectrum, French, Leon, Grevet, Eugenio H, Groenewold, Nynke A, Grotegerd, Dominik, Gruber, Oliver, Gruner, Patricia, Guerrero-Pedraza, Amalia, Gur, Raquel E, Gur, Ruben C, Haar, Shlomi, Haarman, Bartholomeus C M, Thomopoulos, Sophia I, Haavik, Jan, Hahn, Tim, Hajek, Tomas, Harrison, Benjamin J, Harrison, Neil A, Hartman, Catharina A, Whalley, Heather C, Heslenfeld, Dirk J, Hibar, Derrek P, Hilland, Eva, Pozzi, Elena, Hirano, Yoshiyuki, Ho, Tiffany C, Hoekstra, Pieter J, Hoekstra, Liesbeth, Hohmann, Sarah, Hong, L. E., Höschl, Cyril, Høvik, Marie F, Howells, Fleur M, Nenadic, Igor, Abe, Yoshinari, Jalbrzikowski, Maria, James, Anthony C, Janssen, Joost, Jaspers-Fayer, Fern, Xu, Jian, Jonassen, Rune, Karkashadze, Georgii, King, Joseph A, Kircher, Tilo, Kirschner, Matthias, Abé, Christoph, Koch, Kathrin, Kochunov, Peter, Kohls, Gregor, Konrad, Kerstin, Krämer, Bernd, Krug, Axel, Kuntsi, Jonna, Kwon, Jun Soo, Landén, Mikael, Landrø, Nils I, Anticevic, Alan, Lazaro, Luisa, Lebedeva, Irina S, Leehr, Elisabeth J, Lera-Miguel, Sara, Lesch, Klaus-Peter, Lochner, Christine, Louza, Mario R, Luna, Beatriz, Lundervold, Astri J, MacMaster, Frank P, Alda, Martin, Maglanoc, Luigi A, Malpas, Charles B, Portella, Maria J, Marsh, Rachel, Martyn, Fiona M, Mataix-Cols, David, Mathalon, Daniel H, McCarthy, Hazel, McDonald, Colm, McPhilemy, Genevieve, Aleman, Andre, Meinert, Susanne, Menchón, José M, Minuzzi, Luciano, Mitchell, Philip B, Moreno, Carmen, Morgado, Pedro, Muratori, Filippo, Murphy, Clodagh M, Murphy, Declan, Mwangi, Benson, Alloza, Clara, Nabulsi, Leila, Nakagawa, Akiko, Nakamae, Takashi, Namazova, Leyla, Narayanaswamy, Janardhanan, Jahanshad, Neda, Nguyen, Danai D, Nicolau, Rosa, O'Gorman Tuura, Ruth L, O'Hearn, Kirsten, Alonso-Lana, Silvia, Oosterlaan, Jaap, Opel, Nils, Ophoff, Roel A, Oranje, Bob, García de la Foz, Victor Ortiz, Overs, Bronwyn J, Paloyelis, Yannis, Pantelis, Christos, Parellada, Mara, Pauli, Paul, Disorder, Bipolar, Ameis, Stephanie H, Picó-Pérez, Maria, Picon, Felipe A, Piras, Fabrizio, Piras, Federica, Plessen, Kerstin J, Pomarol-Clotet, Edith, Preda, Adrian, Puig, Olga, Quidé, Yann, Radua, Joaquim, Anagnostou, Evdokia, Ramos-Quiroga, J Antoni, Rasser, Paul E, Rauer, Lisa, Reddy, Janardhan, Redlich, Ronny, Reif, Andreas, Reneman, Liesbeth, Repple, Jonathan, Retico, Alessandra, Richarte, Vanesa, McIntosh, Andrew A, Richter, Anja, Rosa, Pedro G P, Rubia, Katya K, Hashimoto, Ryota, Sacchet, Matthew D, Salvador, Raymond, Santonja, Javier, Sarink, Kelvin, Sarró, Salvador, Satterthwaite, Theodore D, Arango, Celso, Sawa, Akira, Schall, Ulrich, Schofield, Peter R, Schrantee, Anouk, Seitz, Jochen, Serpa, Mauricio H, Setién-Suero, Esther, Shaw, Philip, Shook, Devon, Silk, Tim J, Arnold, Paul D, Sim, Kang, Simon, Schmitt, Simpson, Helen Blair, Singh, Aditya, Skoch, Antonin, Skokauskas, Norbert, Soares, Jair C, Soreni, Noam, Soriano-Mas, Carles, Spalletta, Gianfranco, Asherson, Philip, Spaniel, Filip, Lawrie, Stephen M, Stern, Emily R, Stewart, S Evelyn, Takayanagi, Yoichiro, Temmingh, Henk S, Tolin, David F, Tomecek, David, Tordesillas-Gutiérrez, Diana, Tosetti, Michela, Assogna, Francesca, Uhlmann, Anne, van Amelsvoort, Therese, van der Wee, Nic J A, van der Werff, Steven J A, van Haren, Neeltje E M, van Wingen, Guido A, Vance, Alasdair, Vázquez-Bourgon, Javier, Vecchio, Daniela, Venkatasubramanian, Ganesan, Auzias, Guillaume, Vieta, Eduard, Vilarroya, Oscar, Vives-Gilabert, Yolanda, Voineskos, Aristotle N, Völzke, Henry, von Polier, Georg G, Walton, Esther, Weickert, Thomas W, Weickert, Cynthia Shannon, Weideman, Andrea S, Ayesa-Arriola, Rosa, Wittfeld, Katharina, Wolf, Daniel H, Wu, Mon-Ju, Yang, T. T., Yang, Sikun, Yoncheva, Yuliya, Yun, Je-Yeon, Cheng, Yuqi, Zanetti, Marcus V, Ziegler, Georg C, Bakker, Geor, Franke, Barbara, Hoogman, Martine, Buitelaar, Jan K, van Rooij, Daan, Andreassen, Ole A, Ching, Christopher R K, Veltman, Dick J, Schmaal, Lianne, Stein, Dan J, van den Heuvel, Odile A, Disorder, Major Depressive, Banaj, Nerisa, Turner, Jessica A, van Erp, Theo G M, Pausova, Zdenka, Thompson, Paul M, Paus, Tomáš, Attention-Deficit/Hyperactivity Disorder, Banaschewski, Tobias, Bandeira, Cibele E, Baranov, Alexandr, Bargalló, Núria, Bau, Claiton H D, Baumeister, Sarah, Baune, Bernhard T, Bellgrove, Mark A, Benedetti, Francesco, Disorder, Obsessive-Compulsive, Bertolino, Alessandro, Boedhoe, Premika S W, Boks, Marco, Bollettini, Irene, Del Mar Bonnin, Caterina, Borgers, Tiana, Borgwardt, Stefan, Brandeis, Daniel, Brennan, Brian P, Bruggemann, Jason M, Groups, Schizophrenia ENIGMA Working, Bülow, Robin, Busatto, Geraldo F, Calderoni, Sara, Calhoun, Vince D, Calvo, Rosa, Canales-Rodríguez, Erick J, Cannon, Dara M, Carr, Vaughan J, Cascella, Nicola, Cercignani, Mara, Patel, Yash, Chaim-Avancini, Tiffany M, Christakou, Anastasia, Coghill, David, Conzelmann, Annette, Crespo-Facorro, Benedicto, Cubillo, Ana I, Cullen, Kathryn R, Cupertino, Renata B, Daly, Eileen, Dannlowski, Udo, Parker, Nadine, Davey, Christopher G, Denys, Damiaan, Deruelle, Christine, Di Giorgio, Annabella, Dickie, Erin W, Dima, Danai, Dohm, Katharina, Ehrlich, Stefan, Ely, Benjamin A, Erwin-Grabner, Tracy, Shin, Jean, Ethofer, Thomas, Fair, Damien A, Fallgatter, Andreas, Faraone, Stephen V, Fatjó-Vilas, Mar, Fedor, Jennifer M, Fitzgerald, Kate D, Ford, Judith M, Frodl, Thomas, Fu, Cynthia H Y, Howard, Derek, Fullerton, Janice M, Gabel, Matt C, Glahn, David C, Roberts, Gloria, Gogberashvili, Tinatin, Goikolea, Jose M, Gotlib, Ian H, Goya-Maldonado, Roberto, Grabe, Hans, Green, Melissa J, Patel, Y., Parker, N., Shin, J., Howard, D., French, L., Thomopoulos, S. I., Pozzi, E., Abe, Y., Abe, C., Anticevic, A., Alda, M., Aleman, A., Alloza, C., Alonso-Lana, S., Ameis, S. H., Anagnostou, E., Mcintosh, A. A., Arango, C., Arnold, P. D., Asherson, P., Assogna, F., Auzias, G., Ayesa-Arriola, R., Bakker, G., Banaj, N., Banaschewski, T., Bandeira, C. E., Baranov, A., Bargallo, N., Bau, C. H. D., Baumeister, S., Baune, B. T., Bellgrove, M. A., Benedetti, F., Bertolino, A., Boedhoe, P. S. W., Boks, M., Bollettini, I., Del Mar Bonnin, C., Borgers, T., Borgwardt, S., Brandeis, D., Brennan, B. P., Bruggemann, J. M., Bulow, R., Busatto, G. F., Calderoni, S., Calhoun, V. D., Calvo, R., Canales-Rodriguez, E. J., Cannon, D. M., Carr, V. J., Cascella, N., Cercignani, M., Chaim-Avancini, T. M., Christakou, A., Coghill, D., Conzelmann, A., Crespo-Facorro, B., Cubillo, A. I., Cullen, K. R., Cupertino, R. B., Daly, E., Dannlowski, U., Davey, C. G., Denys, D., Deruelle, C., Di Giorgio, A., Dickie, E. W., Dima, D., Dohm, K., Ehrlich, S., Ely, B. A., Erwin-Grabner, T., Ethofer, T., Fair, D. A., Fallgatter, A. J., Faraone, S. V., Fatjo-Vilas, M., Fedor, J. M., Fitzgerald, K. D., Ford, J. M., Frodl, T., Fu, C. H. Y., Fullerton, J. M., Gabel, M. C., Glahn, D. C., Roberts, G., Gogberashvili, T., Goikolea, J. M., Gotlib, I. H., Goya-Maldonado, R., Grabe, H. J., Green, M. J., Grevet, E. H., Groenewold, N. A., Grotegerd, D., Gruber, O., Gruner, P., Guerrero-Pedraza, A., Gur, R. E., Gur, R. C., Haar, S., Haarman, B. C. M., Haavik, J., Hahn, T., Hajek, T., Harrison, B. J., Harrison, N. A., Hartman, C. A., Whalley, H. C., Heslenfeld, D. J., Hibar, D. P., Hilland, E., Hirano, Y., Ho, T. C., Hoekstra, P. J., Hoekstra, L., Hohmann, S., Hong, L. E., Hoschl, C., Hovik, M. F., Howells, F. M., Nenadic, I., Jalbrzikowski, M., James, A. C., Janssen, J., Jaspers-Fayer, F., Xu, J., Jonassen, R., Karkashadze, G., King, J. A., Kircher, T., Kirschner, M., Koch, K., Kochunov, P., Kohls, G., Konrad, K., Kramer, B., Krug, A., Kuntsi, J., Kwon, J. S., Landen, M., Landro, N. I., Lazaro, L., Lebedeva, I. S., Leehr, E. J., Lera-Miguel, S., Lesch, K. -P., Lochner, C., Louza, M. R., Luna, B., Lundervold, A. J., Macmaster, F. P., Maglanoc, L. A., Malpas, C. B., Portella, M. J., Marsh, R., Martyn, F. M., Mataix-Cols, D., Mathalon, D. H., Mccarthy, H., Mcdonald, C., Mcphilemy, G., Meinert, S., Menchon, J. M., Minuzzi, L., Mitchell, P. B., Moreno, C., Morgado, P., Muratori, F., Murphy, C. M., Murphy, D., Mwangi, B., Nabulsi, L., Nakagawa, A., Nakamae, T., Namazova, L., Narayanaswamy, J., Jahanshad, N., Nguyen, D. D., Nicolau, R., O'Gorman Tuura, R. L., O'Hearn, K., Oosterlaan, J., Opel, N., Ophoff, R. A., Oranje, B., Garcia De La Foz, V. O., Overs, B. J., Paloyelis, Y., Pantelis, C., Parellada, M., Pauli, P., Pico-Perez, M., Picon, F. A., Piras, F., Plessen, K. J., Pomarol-Clotet, E., Preda, A., Puig, O., Quide, Y., Radua, J., Ramos-Quiroga, J. A., Rasser, P. E., Rauer, L., Reddy, J., Redlich, R., Reif, A., Reneman, L., Repple, J., Retico, A., Richarte, V., Richter, A., Rosa, P. G. P., Rubia, K. K., Hashimoto, R., Sacchet, M. D., Salvador, R., Santonja, J., Sarink, K., Sarro, S., Satterthwaite, T. D., Sawa, A., Schall, U., Schofield, P. R., Schrantee, A., Seitz, J., Serpa, M. H., Setien-Suero, E., Shaw, P., Shook, D., Silk, T. J., Sim, K., Simon, S., Simpson, H. B., Singh, A., Skoch, A., Skokauskas, N., Soares, J. C., Soreni, N., Soriano-Mas, C., Spalletta, G., Spaniel, F., Lawrie, S. M., Stern, E. R., Stewart, S. E., Takayanagi, Y., Temmingh, H. S., Tolin, D. F., Tomecek, D., Tordesillas-Gutierrez, D., Tosetti, M., Uhlmann, A., Van Amelsvoort, T., Van Der Wee, N. J. A., Van Der Werff, S. J. A., Van Haren, N. E. M., Van Wingen, G. A., Vance, A., Vazquez-Bourgon, J., Vecchio, D., Venkatasubramanian, G., Vieta, E., Vilarroya, O., Vives-Gilabert, Y., Voineskos, A. N., Volzke, H., Von Polier, G. G., Walton, E., Weickert, T. W., Weickert, C. S., Weideman, A. S., Wittfeld, K., Wolf, D. H., Wu, M. -J., Yang, T. T., Yang, K., Yoncheva, Y., Yun, J. -Y., Cheng, Y., Zanetti, M. V., Ziegler, G. C., Franke, B., Hoogman, M., Buitelaar, J. K., Van Rooij, D., Andreassen, O. A., Ching, C. R. K., Veltman, D. J., Schmaal, L., Stein, D. J., Van Den Heuvel, O. A., Turner, J. A., Van Erp, T. G. M., Pausova, Z., Thompson, P. M., Paus, T., Institut de Neurosciences de la Timone (INT), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Pediatric surgery, Radiology and nuclear medicine, Anatomy and neurosciences, Psychiatry, Amsterdam Neuroscience - Brain Imaging, Amsterdam Neuroscience - Compulsivity, Impulsivity & Attention, Amsterdam Neuroscience - Mood, Anxiety, Psychosis, Stress & Sleep, Amsterdam Neuroscience - Neurodegeneration, Psychiatrie & Neuropsychologie, RS: MHeNs - R2 - Mental Health, MUMC+: MA Med Staf Spec Psychiatrie (9), Adult Psychiatry, ANS - Compulsivity, Impulsivity & Attention, General Paediatrics, ARD - Amsterdam Reproduction and Development, Radiology and Nuclear Medicine, APH - Personalized Medicine, ANS - Brain Imaging, ANS - Mood, Anxiety, Psychosis, Stress & Sleep, APH - Mental Health, University of Zurich, Clinical Cognitive Neuropsychiatry Research Program (CCNP), Clinical Neuropsychology, Interdisciplinary Centre Psychopathology and Emotion regulation (ICPE), Child and Adolescent Psychiatry / Psychology, IBBA, and Cognitive Psychology

Subjects
Male, Obsessive-Compulsive Disorder, Bipolar Disorder, Autism Spectrum Disorder, Autism, [SDV]Life Sciences [q-bio], Gene Expression, cytology [Cerebral Cortex], Cohort Studies, Fetal Development, physiology [Gene Expression], 2738 Psychiatry and Mental Health, 0302 clinical medicine, diagnostic imaging [Cerebral Cortex], SCHIZOPHRENIA, BRAIN, Child, Obsessive-compulsive disorder (OCD), Original Investigation, Aged, 80 and over, Cerebral Cortex, 0303 health sciences, pathology [Depressive Disorder, Major], Principal Component Analysis, Adolescent psychiatry, 10058 Department of Child and Adolescent Psychiatry, Middle Aged, diagnostic imaging [Obsessive-Compulsive Disorder], REGIONS, Magnetic Resonance Imaging, 3. Good health, FALSE DISCOVERY RATE, Psychiatry and Mental health, Autism spectrum disorder, Schizophrenia, growth & development [Cerebral Cortex], Child, Preschool, Major depressive disorder, diagnostic imaging [Schizophrenia], Esquizofrènia, Female, Psiquiatria infantil, Psiquiatria de l'adolescència, diagnostic imaging [Autism Spectrum Disorder], Adult, medicine.medical_specialty, Adolescent, Human Development, 610 Medicine & health, diagnostic imaging [Bipolar Disorder], pathology [Autism Spectrum Disorder], diagnostic imaging [Depressive Disorder, Major], 03 medical and health sciences, Young Adult, All institutes and research themes of the Radboud University Medical Center, Neuroimaging, SDG 3 - Good Health and Well-being, CEREBRAL-CORTEX, Child psychiatry, medicine, Attention deficit hyperactivity disorder, Humans, Bipolar disorder, ddc:610, Psychiatry, pathology [Schizophrenia], 030304 developmental biology, Aged, Depressive Disorder, Major, Neurodevelopmental disorders Donders Center for Medical Neuroscience [Radboudumc 7], business.industry, DENDRITE, Computational Biology, Correction, pathology [Attention Deficit Disorder with Hyperactivity], physiology [Fetal Development], medicine.disease, PATHOLOGY, pathology [Bipolar Disorder], pathology [Obsessive-Compulsive Disorder], 10036 Medical Clinic, Attention Deficit Disorder with Hyperactivity, 10054 Clinic for Psychiatry, Psychotherapy, and Psychosomatics, Case-Control Studies, DENSITY, ORIGINS, HIPPOCAMPUS, diagnostic imaging [Attention Deficit Disorder with Hyperactivity], pathology [Cerebral Cortex], Autisme, business, Neuroscience, 030217 neurology & neurosurgery, physiology [Human Development]
Abstract

[Importance] Large-scale neuroimaging studies have revealed group differences in cortical thickness across many psychiatric disorders. The underlying neurobiology behind these differences is not well understood., [Objective] To determine neurobiologic correlates of group differences in cortical thickness between cases and controls in 6 disorders: attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), bipolar disorder (BD), major depressive disorder (MDD), obsessive-compulsive disorder (OCD), and schizophrenia., [Design, Setting, and Participants] Profiles of group differences in cortical thickness between cases and controls were generated using T1-weighted magnetic resonance images. Similarity between interregional profiles of cell-specific gene expression and those in the group differences in cortical thickness were investigated in each disorder. Next, principal component analysis was used to reveal a shared profile of group difference in thickness across the disorders. Analysis for gene coexpression, clustering, and enrichment for genes associated with these disorders were conducted. Data analysis was conducted between June and December 2019. The analysis included 145 cohorts across 6 psychiatric disorders drawn from the ENIGMA consortium. The numbers of cases and controls in each of the 6 disorders were as follows: ADHD: 1814 and 1602; ASD: 1748 and 1770; BD: 1547 and 3405; MDD: 2658 and 3572; OCD: 2266 and 2007; and schizophrenia: 2688 and 3244., [Main Outcomes and Measures] Interregional profiles of group difference in cortical thickness between cases and controls., [Results] A total of 12 721 cases and 15 600 controls, ranging from ages 2 to 89 years, were included in this study. Interregional profiles of group differences in cortical thickness for each of the 6 psychiatric disorders were associated with profiles of gene expression specific to pyramidal (CA1) cells, astrocytes (except for BD), and microglia (except for OCD); collectively, gene-expression profiles of the 3 cell types explain between 25% and 54% of variance in interregional profiles of group differences in cortical thickness. Principal component analysis revealed a shared profile of difference in cortical thickness across the 6 disorders (48% variance explained); interregional profile of this principal component 1 was associated with that of the pyramidal-cell gene expression (explaining 56% of interregional variation). Coexpression analyses of these genes revealed 2 clusters: (1) a prenatal cluster enriched with genes involved in neurodevelopmental (axon guidance) processes and (2) a postnatal cluster enriched with genes involved in synaptic activity and plasticity-related processes. These clusters were enriched with genes associated with all 6 psychiatric disorders., [Conclusions and Relevance] In this study, shared neurobiologic processes were associated with differences in cortical thickness across multiple psychiatric disorders. These processes implicate a common role of prenatal development and postnatal functioning of the cerebral cortex in these disorders.

Published
2021
Full Text
View/download PDF

39. A study on the bioequivalence of lithium and valproate salivary and blood levels in the treatment of bipolar disorder.

Author

Murru A, Torra M, Callari A, Pacchiarotti I, Romero S, Gonzalez de la Presa B, Varo C, Goikolea JM, Pérez-Sola V, Vieta E, and Colom F

Subjects
Adult, Female, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Therapeutic Equivalency, Antidepressive Agents metabolism, Antidepressive Agents pharmacokinetics, Antidepressive Agents therapeutic use, Bipolar Disorder drug therapy, Bipolar Disorder metabolism, Lithium Chloride metabolism, Lithium Chloride pharmacokinetics, Lithium Chloride therapeutic use, Saliva chemistry, Valproic Acid metabolism, Valproic Acid pharmacokinetics, Valproic Acid therapeutic use
Abstract

Lithium (Li) and valproate (VPA) are used in the treatment of bipolar disorder (BD), with narrow therapeutic window requiring periodic control of serum levels. This prevents intoxication, lack of efficacy due to low serum concentrations, and allows monitoring adherence. We aimed at evaluating the bioequivalence of salivary and blood levels of LI or VPA in a sample of adult BD patients. Secondarily, lithium bioequivalence was evaluated across different patients' lifespans. BD patients treated with either Li or VPA underwent contemporary standard serum and salivary measurements. Blood levels of both drugs were taken according to standard procedures. Li salivary levels were performed by an adapted potentiometric method on the AVL9180 electrolyte analyzer. VPA salivary levels were taken with an immune-assay method with turbidimetric inhibition. A total of 50 patients (38 on Li, 12 on VPA) were enrolled. Blood-saliva bioequivalence for VPA was not found due to a high variability in salivary measures. Li measures resulted in a high correlation (r=0.767, p<0.001), showing no partial correlation with age (r=0.147, p=0.380). Li salivary test is a reliable method of measuring Li availability and is equivalent to serum levels. Potential advantages of Li salivary testing are its non-invasive nature and the possibility of doing the test during the usual appointment with the psychiatrist., (Copyright © 2017 Elsevier B.V. and ECNP. All rights reserved.)

Published
2017
Full Text
View/download PDF

40. Clinical guideline for the treatment of dual pathology in the adult population.

Author

San L, Arranz B, Dual Pathology Clinical Practice Guide EG, Arrojo M, Becoña E, Bernardo M, Caballero L, Castells X, Cunill R, Florez G, Franco MD, Garriga M, Goikolea JM, González-Pinto A, Landabaso M, López A, Martinez-Raga J, Merino A, Paramo M, Rubio G, Safont G, Saiz PA, Solà I, Tirado J, Torrens M, and Zorrilla I

Subjects
Adult, Humans, Diagnosis, Dual (Psychiatry), Practice Guidelines as Topic
Published
2016
Full Text
View/download PDF

41. Genetic variability at IMPA2, INPP1 and GSK3β increases the risk of suicidal behavior in bipolar patients.

Author

Jiménez E, Arias B, Mitjans M, Goikolea JM, Roda E, Sáiz PA, García-Portilla MP, Burón P, Bobes J, Oquendo MA, Vieta E, and Benabarre A

Subjects
Alleles, Bipolar Disorder genetics, Case-Control Studies, Female, Glycogen Synthase Kinase 3 beta, Haplotypes, Humans, Male, Middle Aged, Polymorphism, Single Nucleotide, Bipolar Disorder psychology, Genetic Predisposition to Disease genetics, Glycogen Synthase Kinase 3 genetics, Phosphoric Monoester Hydrolases genetics, Suicide, Attempted psychology
Abstract

Bipolar patients (BP) are at high risk of suicide. Causal factors underlying suicidal behavior are still unclear. However, it has been shown that lithium has antisuicidal properties. Genes involved in its putative mechanism of action such as the phosphoinositol and the Wnt/β-catenine pathways could be considered candidates for suicidal behavior (SB). Our aim was to investigate the association of the IMPA1 and 2, INPP1, GSK3α and β genes with suicidal behavior in BP. 199 BP were recruited. Polymorphisms at the IMPA1 (rs915, rs1058401 and rs2268432) and IMPA2 (rs66938, rs1020294, rs1250171 and rs630110), INPP1 (rs3791809, rs4853694 and 909270), GSK3α (rs3745233) and GSK3β (rs334558, rs1732170 and rs11921360) genes were genotyped. All patients were grouped and compared according to the presence or not of history of SB (defined as the presence of at least one previous suicidal attempt). Single SNP analyses showed that suicide attempters had higher frequencies of AA genotype of the rs669838-IMPA2 and GG genotype of the rs4853694-INPP1gene compared to non-attempters. Results also revealed that T-allele carriers of the rs1732170-GSK3β gene and A-allele carriers of the rs11921360-GSK3β gene had a higher risk for attempting suicide. Haplotype analysis showed that attempters had lower frequencies of A:A haplotype (rs4853694:rs909270) at the INPP1 gene. Higher frequencies of the C:A haplotype and lower frequencies of the A:C haplotype at the GSK-3β gene (rs1732170:rs11921360) were also found to be associated to SB in BP. Therefore, our results suggest that genetic variability at IMPA2, INPP1 and GSK3β genes is associated with the emergence of SB in BP., (Copyright © 2013 Elsevier B.V. and ECNP. All rights reserved.)

Published
2013
Full Text
View/download PDF

42. Faster onset of antimanic action with haloperidol compared to second-generation antipsychotics. A meta-analysis of randomized clinical trials in acute mania.

Author

Goikolea JM, Colom F, Capapey J, Torres I, Valenti M, Grande I, Undurraga J, and Vieta E

Subjects
Acute Disease, Bipolar Disorder diagnosis, Humans, Randomized Controlled Trials as Topic methods, Time Factors, Treatment Outcome, Antimanic Agents therapeutic use, Antipsychotic Agents therapeutic use, Bipolar Disorder drug therapy, Bipolar Disorder psychology, Haloperidol therapeutic use
Abstract

Background: there is a lack of scientific data regarding speed of action of antimanic treatments, a relevant issue in clinical practice., Objective: to assess differences in the speed of onset of antimanic efficacy between haloperidol (as most studied first-generation antipsychotic) and second-generation antipsychotics., Experimental Procedures: meta-analysis of double-blind randomized clinical trials in acute mania, comparing treatment with haloperidol and with second-generation antipsychotics. Search was conducted in MEDLINE and CENTRAL databases (last search: September 2011). Differences in mania scale score reduction at week 1 were assessed., Results: 8 randomized clinical trials fulfilled inclusion criteria and 1 of them was excluded due to low methodological quality. 2037 Manic patients had been treated with antipsychotics in the 7 trials. Haloperidol was found to be significantly more efficacious in the reduction of the mania scale score at week 1. The effect size was small, the Standardized Mean Difference (SMD) being 0.17, with a 95% Confidence Interval ranging from 0.01 to 0.32. Haloperidol was significantly more efficacious than olanzapine (SMD: 0.40 [0.21, 0.59]) and ziprasidone (0.39 [0.18, 0.61]). A non-significant trend towards superiority of haloperidol was found over aripiprazole (SMD: 0.13 [-0.02, 0.19]). There were no significant differences between haloperidol and quetiapine (0.17 [-0.11, 0.44]), and haloperidol and risperidone (SMD: -0.10 [0.30, 0.09])., Conclusions: haloperidol shows a faster onset of antimanic action than second-generation antipsychotics. This difference may be related to D2 affinity. Haloperidol may be considered a treatment option in severely ill manic patients who require urgent relief of symptoms., (Copyright © 2012 Elsevier B.V. and ECNP. All rights reserved.)

Published
2013
Full Text
View/download PDF

43. Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol.

Author

Goikolea JM, Colom F, Torres I, Capapey J, Valentí M, Undurraga J, Grande I, Sanchez-Moreno J, and Vieta E

Subjects
Acute Disease, Aripiprazole, Benzodiazepines therapeutic use, Depression prevention & control, Depressive Disorder drug therapy, Dibenzothiazepines therapeutic use, Double-Blind Method, Drug Industry, Humans, Olanzapine, Piperazines therapeutic use, Quetiapine Fumarate, Quinolones therapeutic use, Randomized Controlled Trials as Topic methods, Research Support as Topic, Risperidone therapeutic use, Thiazoles therapeutic use, Antimanic Agents therapeutic use, Antipsychotic Agents therapeutic use, Bipolar Disorder drug therapy, Depressive Disorder prevention & control, Haloperidol therapeutic use
Abstract

Background: Treatment of acute mania with second-generation antipsychotics has been claimed to involve a lower risk of switch to depression than haloperidol. However, clinical guidelines clearly state that this is not a proven fact., Methods: Meta-analysis of double-blind randomized controlled trials in acute mania, comparing rates of switch to depression with atypical antipsychotics and with haloperidol. Search was conducted in MEDLINE and CENTRAL databases (last search: September 2011)., Results: 8 randomized clinical trials fulfilled inclusion criteria. 2 of them were excluded because of low methodological quality or lack of data. 5 second-generation antipsychotics (aripiprazole, olanzapine, quetiapine, risperidone, and ziprasidone) were compared to haloperidol. In the mixed effects model the Risk Ratio for depressive switch was 0.71 (0.52, 0.96) favouring atypical antipsychotics. In the random effects model the difference did not reach statistical significance. In the heterogeneity analysis, exclusion of an outlying aripiprazole trial yielded a Risk Ratio of 0.58 (0.42, 0.82) with a non-significant heterogeneity test. Although no atypical antipsychotic was individually significantly superior to haloperidol, a trend could be seen favouring olanzapine (RR=0.56 [0.29, 1.08]), quetiapine (RR=0.36 [0.10, 1.33]), and ziprasidone (RR=0.51 [0.22, 1.18])., Limitations: All trials were industry supported, with some variability in dosage of haloperidol. Switch to depression was not the primary outcome of the trials. Heterogeneity could be explained as a lack of class-effect for atypicals., Conclusions: Treating acute mania with atypicals is associated to 42% less risk of switch to depression than with haloperidol. Nevertheless, caution should be taken when considering this a class effect, as only olanzapine, quetiapine, and ziprasidone may show a better profile., (Copyright © 2012 Elsevier B.V. All rights reserved.)

Published
2013
Full Text
View/download PDF

44. Executive dysfunction and memory impairment in schizoaffective disorder: a comparison with bipolar disorder, schizophrenia and healthy controls.

Author

Amann B, Gomar JJ, Ortiz-Gil J, McKenna P, Sans-Sansa B, Sarró S, Moro N, Madre M, Landin-Romero R, Vieta E, Goikolea JM, Salvador R, and Pomarol-Clotet E

Subjects
Adult, Analysis of Variance, Bipolar Disorder epidemiology, Bipolar Disorder psychology, Cognition Disorders epidemiology, Cognition Disorders psychology, Comorbidity, Female, Humans, Male, Memory Disorders epidemiology, Memory Disorders psychology, Neuropsychological Tests statistics & numerical data, Psychotic Disorders epidemiology, Psychotic Disorders psychology, Schizophrenia epidemiology, Schizophrenic Psychology, Spain epidemiology, Bipolar Disorder physiopathology, Cognition Disorders physiopathology, Executive Function, Memory Disorders physiopathology, Psychotic Disorders physiopathology, Schizophrenia physiopathology
Abstract

Background: Deficits in memory and executive performance are well-established features of bipolar disorder and schizophrenia. By contrast, data on cognitive impairment in schizoaffective disorder are scarce and the findings are conflicting., Method: We used the Wechsler Memory Scale (WMS-III) and the Behavioural Assessment of the Dysexecutive Syndrome (BADS) to test memory and executive function in 45 schizophrenic patients, 26 schizomanic patients and 51 manic bipolar patients in comparison to 65 healthy controls. The patients were tested when acutely ill., Results: All three patient groups performed significantly more poorly than the controls on global measures of memory and executive functioning, but there were no differences among the patient groups. There were few differences in memory and executive function subtest scores within the patient groups. There were no differences in any test scores between manic patients with and without psychotic symptoms., Conclusions: Schizophrenic, schizomanic and manic patients show a broadly similar degree of executive and memory deficits in the acute phase of illness. Our results do not support a categorical differentiation across different psychotic categories with regard to neuropsychological deficits.

Published
2012
Full Text
View/download PDF

45. Subthreshold symptoms in bipolar disorder: impact on neurocognition, quality of life and disability.

Author

Bonnín CM, Sánchez-Moreno J, Martínez-Arán A, Solé B, Reinares M, Rosa AR, Goikolea JM, Benabarre A, Ayuso-Mateos JL, Ferrer M, Vieta E, and Torrent C

Subjects
Activities of Daily Living psychology, Adult, Bipolar Disorder diagnosis, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Psychology, Quality of Life, Bipolar Disorder psychology, Cognition
Abstract

Objective: To provide empirical evidence of the effect of subthreshold symptomatology (both depressive and manic) on psychosocial functioning, neurocognition and quality of life in bipolar disorder., Methods: A total of 133 participants were enrolled for this study (bipolar patients, n=103; healthy controls, n=30). Patients were divided into two groups according to their levels of subthreshold symptomatology: the subsyndromic group was constituted by those patients with upper levels of subthreshold symptomatology (HDRS≥4 and YMRS≥3) and the asymptomatic group represented the patients with lower scores (HDRS≤3 and YMRS≤2). All participants were administered a comprehensive neuropsychological battery. Moreover the patients answered the SF-36 (Quality of Life, QoL) and were interviewed with the WHODAS-2 (Psychosocial functioning and disability). One-way ANOVA were used in order to compare the differences between the three groups., Results: The analyses revealed that both patients groups, albeit free of acute symptoms of mania or depression, differed in terms of functioning and disability assessed with the WHODAS-2. Specifically, the total global score of disability was higher for the subsyndromic group indicating more impairment (p=0.008). The same pattern of impairment was found for three of its domains: "understanding and communicating" (p=0.013); "self-care" (p=0.035) and "getting along with others" (p=0.024). The subsyndromic group also scored lower when compared to their counterparts in the Mental Component of QoL of the SF-36 (p=0.045). Finally, in the neuropsychological performance verbal learning and memory was found to be impaired regardless the levels of subthreshold symptomatology, suggesting that this variable is a robust indicator of neuropsychological impairment in BD patients., Conclusions: This report presents empirical data suggesting a moderate impact of subthreshold symptoms on functioning/disability and QoL and a discrete impact on neuropsychological impairment., (Copyright © 2011 Elsevier B.V. All rights reserved.)

Published
2012
Full Text
View/download PDF

46. Impulsivity and functional impairment in bipolar disorder.

Author

Jiménez E, Arias B, Castellví P, Goikolea JM, Rosa AR, Fañanás L, Vieta E, and Benabarre A

Subjects
Adult, Bipolar Disorder diagnosis, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Prognosis, Bipolar Disorder psychology, Depression psychology, Impulsive Behavior psychology
Abstract

Background: Impulsivity is substantially higher in bipolar patients (BP) and may be associated with a more severe course of illness, but no studies have so far examined the relationship between impulsivity and functional outcome in BP. Our goal was to investigate the functional impact of trait-impulsivity in BP., Methods: 138 euthymic BP were recruited. All patients were assessed using an interview based on the Structured Clinical Interview for DSM Disorders (SCID). The Functioning Assessment Short Test (FAST) and the Barratt Impulsiveness Scale (BIS-11) were used to assess functional outcome and impulsivity, respectively. Seven multiple linear regressions, with each individual FAST subscale scores and overall FAST score as dependant variables, were conducted in order to evaluate the predictive role of trait-impulsivity on functional outcome., Results: After a multiple linear regression model, with the FAST total score as dependent variable, we found that depressive symptoms (β=1.580; p<0.001), number of hospitalizations (β=0.837; p=0.019) and impulsivity (β=0.319; p=0.004) were independently associated with overall functional impairment (F=6.854, df=9, p<0.001, adjusted R2=0.311)., Limitations: The cross-sectional design of the study., Conclusions: Our results indicate that impulsivity, as well as depressive symptoms and the number of hospitalizations, is associated with overall functional impairment in BP. The assessment and treatment of impulsivity may be useful in improving functional outcome in BP., (Copyright © 2011 Elsevier B.V. All rights reserved.)

Published
2012
Full Text
View/download PDF

47. Postpartum bipolar episodes are not distinct from spontaneous episodes: implications for DSM-V.

Author

Colom F, Cruz N, Pacchiarotti I, Mazzarini L, Goikolea JM, Popova E, Torrent C, and Vieta E

Subjects
Adult, Age of Onset, Bipolar Disorder etiology, Female, Follow-Up Studies, Humans, Middle Aged, Pregnancy, Prospective Studies, Recurrence, Socioeconomic Factors, Young Adult, Bipolar Disorder psychology, Diagnostic and Statistical Manual of Mental Disorders, Postpartum Period psychology
Abstract

Introduction: DSM course modifiers should be based on enough evidence on his impact in the clinical prognosis of patients presenting with a certain clinical feature. The presence of postpartum onset of a mood episode in bipolar disorders has not been sufficiently studied. This is the first prospective clinical study comparing female bipolar patients with and without lifetime history of postpartum mood episode., Methods: Systematic prospective follow-up (12 years) of 200 female bipolar I or II patients with or without history of postpartum episodes. Postpartum mood episode was defined according to DSM-IV criteria. Patients with and without postpartum onset of a mood episode were compared regarding clinical and sociodemographic variables., Results: Lifetime history of postpartum episode was present in 43 patients and absent in 137 patients. Twenty patients were excluded from the study because lack of agreement of the two independent psychiatrist. Both groups showed almost no differences regarding clinical features, functioning or severity., Limitations: The present study does not take account of potential factors that may influence the outcome of a postpartum episode, including obstetric complications and social support before delivery. Similarly, dimensional and qualitative aspects of bipolar disorder were not included in our analysis., Conclusion: The role of postpartum onset as a DSM course modifier should be reconsidered, as it seems to have no impact on prognosis or functioning., (Copyright 2010 Elsevier B.V. All rights reserved.)

Published
2010
Full Text
View/download PDF

48. Psychoeducation for bipolar II disorder: an exploratory, 5-year outcome subanalysis.

Author

Colom F, Vieta E, Sánchez-Moreno J, Goikolea JM, Popova E, Bonnin CM, and Scott J

Subjects
Adult, Bipolar Disorder diagnosis, Bipolar Disorder drug therapy, Combined Modality Therapy, Control Groups, Diagnostic and Statistical Manual of Mental Disorders, Follow-Up Studies, Hospitalization, Humans, Longitudinal Studies, Patient Education as Topic methods, Psychiatric Status Rating Scales, Quality of Life, Randomized Controlled Trials as Topic statistics & numerical data, Secondary Prevention, Single-Blind Method, Social Adjustment, Treatment Outcome, Bipolar Disorder prevention & control, Psychotherapy, Group methods
Abstract

Background: Bipolar II represents a significant subgroup of bipolar patients. However, there is limited evidence regarding the efficacy of pharmacological and/or psychosocial therapies., Method: Post-hoc analyses were undertaken using data on 20 (out of 120) patients who fulfilled DSM-IV criteria for BP II who had participated in a single-blind randomized controlled treatment trial (RCT) exploring the acute and long-term efficacy of group psychoeducation plus standard pharmacological treatment as compared with unstructured support groups plus standard pharmacological treatment. Eight BP II subjects had been randomized to a psychoeducation group and 12 to an unstructured support group., Results: Psychoeducated, as compared to control group bipolar II patients, had significantly better 5-year outcomes, with lower mean number of BP episodes (p<.02), hypomanic episodes (p<.03) and depressive episodes (p<.03), fewer days spent in mood episodes (p=.004) and higher mean levels of functioning (p<.05)., Conclusions: Although these findings should be treated with caution, it appears that psychoeducation plus medication can benefit bipolar II subjects. Dedicated treatment trials will need to clarify whether these therapies require modifications in duration and/or content to meet the needs of bipolar II patients.

Published
2009
Full Text
View/download PDF

49. Bipolar disorder associated to substance use disorders (dual diagnosis). Systematic review of the scientific evidence and expert consensus.

Author

Casas M, Franco MD, Goikolea JM, Jiménez-Arriero MA, Martínez-Raga J, Roncero C, and Szerman N

Subjects
Diagnosis, Dual (Psychiatry), Humans, Bipolar Disorder epidemiology, Expert Testimony, Substance-Related Disorders epidemiology
Abstract

The present work focuses on the so-called dual diagnosis (DD): bipolar disorder (BD) associated with substance use disorders (SUD). Although the psychiatrists who treat patients with BD and physicians in charge of patients with SUD frequently find this association with DD, unfortunately there are few scientific works that have studied this association. The Spanish Working Group on Bipolar Disorders in Dual Diagnosis reviewed the published material using a Medline search and selected the most relevant articles. Following this, the Work Group developed an expert consensus in DD and finally, a survey was performed among a group of experts in this disorder to cover the areas that were not fully addressed by the scientific evidence or in those areas in which the Work Group was unable to reach a consensus. We conclude that, in view of the above, establishment of a consensus is a valid tool to complement the current scientific evidence.

Published
2008

50. What really matters to bipolar patients' caregivers: sources of family burden.

Author

Reinares M, Vieta E, Colom F, Martínez-Arán A, Torrent C, Comes M, Goikolea JM, Benabarre A, Daban C, and Sánchez-Moreno J

Subjects
Adult, Bipolar Disorder diagnosis, Cross-Sectional Studies, Female, Humans, Male, Mental Disorders diagnosis, Mental Disorders psychology, Middle Aged, Patient Compliance psychology, Self Care psychology, Social Adjustment, Spain, Bipolar Disorder psychology, Caregivers psychology, Cost of Illness
Abstract

Background: Identifying and modifying burdensome aspects might reduce the level of burden and their negative effects both on caregivers and patients' outcome. Most studies evaluate acutely ill patients, whereas the most relevant problems may be related to subthreshold symptoms and long-term outcome. The aims of the present study were to assess caregiver's subjective burden, to analyse which were the most burdensome aspects for caregivers and to study which variables could explain the caregiver's subjective burden., Methods: Caregivers of 86 euthymic bipolar patients completed the subjective burden subscale from an adapted version of the Social Behaviour Assessment Schedule., Results: Caregivers showed a moderate level of subjective burden. The highest levels of distress were reported regarding the patient's behaviour; the most distressing behaviours were hyperactivity, irritability, sadness and withdrawal. Regarding the patient's role performance, the most worrying aspects were those associated with the patient's work or study and social relationships. Regarding adverse effects on others, caregivers were especially distressed by the way the illness had affected their emotional health and their life in general. Poorer social and occupational functioning, an episode in the last 2 years, history of rapid cycling and the caregiver being responsible for medication intake explained a quarter of the variance of the caregiver's subjective burden., Limitations: This was a cross-sectional study focused only on primary caregivers, there was no control group of non-bipolar patients., Conclusions: This study provides relevant data concerning the burden of caregivers of stable bipolar patients, pointing at potential targets for psychosocial interventions.

Published
2006
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results